REFERENCES
- Pereira B J. Hepatitis C virus infection in dialysis: A continuing problem. Artif Organs 1999; 23(1)51–60
- Rao K V, Anderson W R, Kasiske B L, Dahl D C. Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients. Am J Med 1993; 94(3)241–250
- Pereira B J, Natov S N, Bouthot B A, Murthy B V, Ruthazer R, Schmid C H, Levey A S. The New England Organ Bank Hepatitis C Study Group. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. Kidney Int 1998; 53(5)1374–1381
- Goffin E, Pirson Y, van Ypersele de Strihou C. Implication of chronic hepatitis B or C infection for renal transplant candidates. Nephrol Dial Transplant 1995; 10(Suppl 6)88–92
- Mathurin P, Mouqet C, Poynard T, Sylla C, Benalia H, Fretz C, Thibault V, Cadranel J F, Bernard B, Opolon P, Coriat P, Bitker M O. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999; 29(1)257–263
- Pol S, Romeo R, Zins B, Driss F, Lebkiri B, Carnot F, Berthelot P, Brechot C. Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications. Kidney Int 1993; 44(5)1097–1100
- Caramelo C, Ortiz A, Aguilera B, Porres J C, Navas S, Marriott E, Alberola M L, Alamo C, Galera A, Garron M P. Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus. Am J Kidney Dis 1993; 22(6)822–828
- Natov S N, Lau J Y, Bouthot B A, Murthy B V, Ruthazer R, Schmid C H, Levey A S, Pereira B J. Serologic and virologic profiles of hepatitis C infection in renal transplant candidates. New England Organ Bank Hepatitis C Study Group. Am J Kidney Dis 1998; 31(6)920–927
- Olynyk J K, Reddy K R, Di Bisceglie A M, Jeffers L J, Parker T I, Radick J L, Schiff E R, Bacon B R. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995; 108(4)1104–1109
- Caramelo C, Albalate M, Bermejillo T, Navas S, Ortiz A, de Sequera P, Casado S, Carreno V. Relationship between plasma ferritin and aminotransferase profile in hemodialysis patients with hepatitis C virus. Nephrol Dial Transplant 1996; 11(9)1792–1796
- Scheuer P J. Classification of chronic viral hepatitis: a need for reassessment. J Hepat 1991; 13(3)372–374
- Desmet V J, Gerber M, Hoofnagle J H, Manns M, Sheuer P J. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19(6)1513–1520
- Batts K P, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995; 19(12)1409–1417
- LeSage G D, Baldus W P, Fairbanks VF, Baggenstoss A H, McCall J T, Moore S B, Taswell H F, Gordon H. Hemachromotosis: genetic or alcohol-induced?. Gastroenterology 1983; 84(6)1471–1477
- Chan T M, Lok A S, Cheng I K, Chan R T. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays. Hepatology 1993; 17(1)5–8
- Picciotto A, Varagona G, Gurreri G, Fiorini F, Sofia A, Coviello D A, Bonanni P, Icardi G C, Valle F, Celle G. Anti-hepatitis C virus antibodies and hepatitis C virus viremia in hemodialysis patients. Nephrol Dial Transplant 1993; 22(4)574–580
- Dussol B, Chicheportiche C, Cantaloube J F, Roubicek C, Biagini P, Berthezene P, Berland Y. Detection of hepatitis C infection by polymerase chain reaction among hemodialysis patients. Am J Kidney Dis 1993; 8: 744–747
- Chan T M, Wu P C, Lau J Y, Lok A S, Lai C L, Cheng I K. Interferon treatment for hepatitis C virus infection in patients on hemodialysis. Nephrol Dial Transplant 1997; 12(7)1414–1419
- Martin P, Carter D, Fabrizi F, Dixit V, Conrad A J, Artinian L, Peacock V, Han S, Wilkinson A, Lassman C R, Danovitch G. Histopathological features of hepatitis C in renal transplant candidates. Transplantation 2000; 69(7)1479–1484
- Guh J Y, Lai Y H, Yang C Y, Chen S C, Chuang W L, Hsu T C, Chen H C, Chang W Y, Tsai J H. Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients. Nephron 1995; 69(4)459–465
- Yasuda K, Okuda K, Endo N, Ishiwatari Y, Ikeda R, Hayashi H, Yokozeki K, Kobayashi S, Irie Y. Hipoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal. Gastroenterology 1995; 109(4)1295–1300
- Roth D, Zucker K, Cirocco R, Burke G, Ciancio G, Esquenazi V, Swanson S J, Miller J. A prospective study of hepatitis C virus infection in renal allograft recipients. Transplantation 1996; 61(6)886–889
- Fabrizi F, Lunghi G, Andrulli S, Pagliari B, Mangano S, Faranna P, Pagano A, Locatelli F. Influence of hepatitis C virus (HCV) viremia upon serum aminotransferase activity in chronic dialysis patients. Nephrol Dial Transplant 1997; 12(7)1394–1398
- Galan F, Perez-Gracia M T, Lozano A, Benavides B, Fernandez-Ruiz E, Rodriquez-Iglesias M A. A 3-year follow-up of HCV-RNA viremia in hemodialysis patients. Nephrol Dial Transplant 1998; 13(5)1211–1214
- Alfurayh O, Sobh M, Buali A, Ali M A, Barri Y, Qunibi W, Taher S. Hepatitis C virus infection in chronic hemodialysis patients, a clinicopathologic study. Nephrol Dial Transplant 1992; 7(4)327–332
- al-Wakeel J, Malik G H, al-Mohaya S, Mitwalli A, Baroudi F, el Gamal H, Kechrid M. Liver disease in dialysis patients with antibodies to hepatitis C virus. Nephrol Dial Transplant 1996; 11(11)2265–2268
- Rampino T, Arbustini E, Gregorini M, Guallini P, Libetta C, Maggio M, Ranghino A, Silini E, Soccio G, Dal Canton A. Kidney Int 1999; 56(6)2286–2291